Disease Control and Elimination, Medical Research Council Unit The Gambia at London School of Hygiene & Tropical Medicine, Fajara, Gambia
Infection and Immunity, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
BMJ Open. 2022 Mar 10;12(3):e056706. doi: 10.1136/bmjopen-2021-056706.
To determine the causes of lobar pneumonia in rural Gambia.
Population-based pneumonia surveillance at seven peripheral health facilities and two regional hospitals in rural Gambia. 7-valent pneumococcal conjugate vaccine (PCV7) was introduced routinely in August 2009 and replaced by PCV13 from May 2011.
Prospective pneumonia surveillance was undertaken among all ages with referral of suspected pneumonia cases to the regional hospitals. Blood culture and chest radiographs were performed routinely while lung or pleural aspirates were collected from selected, clinically stable patients with pleural effusion on radiograph and/or large, dense, peripheral consolidation. We used conventional microbiology, and from 8 April 2011 to 17 July 2012, used a multiplex PCR assay on lung and pleural aspirates. We calculated proportions with pathogens, associations between coinfecting pathogens and PCV effectiveness.
2550 patients were admitted with clinical pneumonia; 741 with lobar pneumonia or pleural effusion. We performed 181 lung or pleural aspirates and multiplex PCR on 156 lung and 4 pleural aspirates.
Pathogens were detected in 116/160 specimens, the most common being (n=68) (n=26) and type b (n=11). Bacteria (n=97) were more common than viruses (n=49). Common viruses were bocavirus (n=11) and influenza (n=11). Coinfections were frequent (n=55). was detected in eight patients and in every case there was coinfection with . The odds ratio of vaccine-type pneumococcal pneumonia in patients with two or three compared with zero doses of PCV was 0.17 (95% CI 0.06 to 0.51).
Lobar pneumonia in rural Gambia was caused primarily by bacteria, particularly and . Coinfection was common and always coinfected with . PCV was highly efficacious against vaccine-type pneumococcal pneumonia.
确定冈比亚农村地区大叶性肺炎的病因。
在冈比亚农村的七个基层卫生机构和两家地区医院进行基于人群的肺炎监测。2009 年 8 月常规接种 7 价肺炎球菌结合疫苗(PCV7),2011 年 5 月用 13 价肺炎球菌结合疫苗(PCV13)替代。
对所有年龄段的人群进行前瞻性肺炎监测,将疑似肺炎病例转诊至地区医院。常规进行血培养和胸部 X 线检查,同时对 X 线检查有胸腔积液和/或大而密集的外周实变的临床稳定的胸腔积液患者采集肺或胸腔抽吸物。我们使用常规微生物学方法,自 2011 年 4 月 8 日至 2012 年 7 月 17 日,使用肺和胸腔抽吸物的多重 PCR 检测方法。我们计算了病原体的比例,以及合并感染病原体与 PCV 有效性之间的关系。
2550 例有临床肺炎的患者入院,741 例患有大叶性肺炎或胸腔积液。我们进行了 181 次肺或胸腔抽吸,对 156 份肺抽吸物和 4 份胸腔抽吸物进行了多重 PCR 检测。
在 160 份标本中检测到 116 份病原体,最常见的病原体是(n=68)(n=26)和 型(n=11)。细菌(n=97)比病毒(n=49)更常见。常见病毒包括博卡病毒(n=11)和流感病毒(n=11)。合并感染很常见(n=55)。在 8 例患者中检测到 ,在每例患者中均与 合并感染。与零剂 PCV 相比,两剂或三剂 PCV 患者的疫苗型肺炎球菌肺炎的优势比为 0.17(95%CI 0.06 至 0.51)。
冈比亚农村地区的大叶性肺炎主要由细菌引起,尤其是 和 。合并感染很常见, 总是与 合并感染。PCV 对疫苗型肺炎球菌肺炎非常有效。